About Enzyre
Our technology will revolutionize blood coagulation management. The ENZYSYSTEM enables real near patient blood coagulation analysis, with the measured data being effortlessly made available to the treating physician, irrespective of his or her physical location.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
enzyre.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised undisclosed · Series-A
fundraisingfox.com
- Capital Raise
Raised $11,870,000 · Series-A
startupintros.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Enzyre.
Funding History
Series-A equity
· Jan 13, 2023
undisclosed fundraisingfox.com
Series-A equity
· Nov 2, 2022
$11,870,000 startupintros.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026